Related Experiment Video
Updated: May 15, 2026
11:31
Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
LRP5 and LRP6 in development and disease.
Danese M Joiner1, Jiyuan Ke, Zhendong Zhong
1Center for Skeletal Disease Research, Laboratory of Cell Signaling and Carcinogenesis, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Trends in Endocrinology and Metabolism: TEM
|December 19, 2012
Summary
Low-density lipoprotein-related receptors 5 and 6 (LRP5/6) are crucial for Wnt signaling and linked to diseases like osteoporosis and cancer. Understanding LRP5/6 structure and interactions aids therapeutic drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Low-density lipoprotein-related receptors 5 and 6 (LRP5/6) are homologous proteins vital for canonical Wnt signaling.
- Genetic alterations in LRP5/6 or interacting proteins are associated with human diseases, including osteoporosis, cancer, and metabolic disorders.
- These receptors are significant targets for therapeutic drug development.
Purpose of the Study:
- To review the link between LRP5/6 alterations and human diseases.
- To discuss proteins interacting with LRP5/6 and their functional implications.
- To highlight current drug development strategies and the impact of LRP5/6 structural elucidation on therapeutic targeting.
Main Methods:
- Literature review of studies on LRP5/6.
- Analysis of genetic data linking LRP5/6 to disease.
- Examination of mouse models to understand LRP5/6 function.
- Review of current pharmaceutical research and development targeting LRP5/6.
Main Results:
- LRP5/6 alterations are implicated in a range of diseases, underscoring their physiological importance.
- Interacting proteins modulate LRP5/6 function, offering additional therapeutic avenues.
- Mouse models have provided critical insights into LRP5/6 roles in development and disease.
- Recent crystal structure data offers opportunities for more precise drug design.
Conclusions:
- LRP5/6 are central to Wnt signaling and disease pathogenesis.
- Targeting LRP5/6 pathways holds significant therapeutic potential for various conditions.
- Advances in structural biology are expected to enhance the development of LRP5/6-targeted therapies.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Related Concept Videos
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:41Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...